PLT Health Solutions Launches cellflo6® Ingredient into Global Markets
Patented, Experiential Ingredient Designed to Provide Improved Sports Performance, Increased Energy and Overall Health Benefits
According to
A novel ingredient with broad-ranging benefits
cellflo6 is a novel, patented, clinically studied, gallate-enhanced oligomer extract sourced from green tea (Camellia sinensis) that contains standardized levels of galloylated procyanidins. The ingredient is the subject of a patent on galloylated procyanidins for treating endovascular dysfunction and increasing blood flow (US Patent No.: US 11,766,422 B2). It has also been shown to support cellular health. cellflo6's unique gallate-enhanced procyanidins fight free radical damage while reducing oxidative stress.*
cellflo6 also provides the many benefits classically associated with green tea catechins. Among these are support for exercise recovery, muscle recovery, metabolic health, and weight management.*
According to
For more information on cellflo6, visit: www.plthealth.com/cellflo6.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
About PLT Health Solutions
Headquartered in
Media Contact: | Company Contact: | |
Mark Falconer | ||
Sciencewerks, LLC | PLT Health Solutions, Inc. | |
E-mail: [email protected] | E-mail: [email protected] | |
201-615-9203 |
View original content:https://www.prnewswire.com/news-releases/plt-health-solutions-launches-cellflo6-ingredient-into-global-markets-302267944.html
SOURCE PLT Health Solutions
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- School Specialty Partners with Tomball ISD to Furnish Future-Ready Texas High School
- Former Commanding General of U.S. Army Special Operations Command Joins Operation Healing Forces National Advisory Council
- Homecare Homebase Report Explores What Clinicians Really Want from Their Employers
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share